Scribe's $129M IPO Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Th Fri 24 July, 2026

J.P. Morgan was the right banking team for Montara Therapeutics. Founder Nicholas Hertz trusted the team’s life sciences expertise, security, and support to focus on what mattered most. sponsored by J.P.Morgan

presented by HIV Ends Here: In­side Vi­iV Health­care’s Sin­gu­lar Mis­sion

news Sanofi nixes Kymab-originated OX40L antibody in eczema Gene editor Scribe Therapeutics starts second-half IPO spree with $129M listing Peer Review Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67

Jul 30 1:00 pm ET Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights sponsored by GUARDANT Aug 19 1:00 pm ET From pilots to production: AI across R&D, safety, regulatory, and clinical sponsored by IBM

Associate Director / Director, Preclinial Development - Immunology Terray Therapeutics, Inc. Monrovia, CA, USA Senior Director, Licensing Officer Bayer Cambridge, MA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

The most differentiated science stays out of public view. This September, the Endpoints newsroom reveals the 11 private companies worth watching, live at the State Room in Boston. See the list first, reserve your spot and save with the early bird rate.

ENDPOINTS PHARMA FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC-157 Sartorius reduces revenue by €26M to refund Trump tariffs to customers FDA to end pilot aimed at preventing production issues

in case you missed it 1. Biogen bets newly acquired Apellis can paper over Leqembi's disappointing sales into 2027 2. Merck CEO cautions Congress on imposing limits on Chinese dealmaking 3. Updated: Lilly's triple agonist heads to regulators after two more Phase 3 obesity wins 4. News Briefing Scancell merges with Neuphoria after Merck axes trial; AstraZeneca breast cancer drug approved in EU 5. Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts near 6. Roche says it is thoughtful on token use for AI, shelves a drug from Carmot buy 7.